Revenue
2017
2018
2019
2020
2021
2022
2023
2024
2025
Regenerative Medical Technology Group Inc. (RMTG)
Price$0.0800Cached quote
Net income
2017
2018
2019
2020
2021
2022
2023
2024
2025
Free cash flow
2018
2019
2020
2022
2023
2024
2025
Total cash / debt
CashTotal debt
2017
2018
2019
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $5.1M | $4.1M | $2.4M | $1.5M | $437,887 | $55,082 | $30,103 | $50,116 | $29,241 |
| Gross profit | $2.8M | $2.8M | $1.7M | $876,967 | $150,137 | $11,128 | −$25,421 | −$18,218 | $24,431 |
| Gross margin | 55.11% | 68.73% | 69.53% | 57.31% | 34.29% | 20.20% | −84.45% | −36.35% | 83.55% |
| Operating expenses | $3.7M | $2.7M | $2.4M | $2.1M | $10.1M | $459,548 | $1.6M | $236,975 | $525,073 |
| Operating income | −$867,162 | $81,181 | −$715,226 | −$1.2M | — | — | — | — | — |
| Operating margin | −17.00% | 1.98% | −29.68% | −77.43% | — | — | — | — | — |
| EBITDA | −$586,095 | $301,740 | −$405,124 | −$1.0M | — | — | — | — | — |
| EBITDA margin | −11.49% | 7.35% | −16.81% | −66.57% | — | — | — | — | — |
| Net income | −$7.8M | −$5.6M | −$9.8M | −$5.5M | −$12.9M | −$5.9M | −$2.5M | −$2.1M | −$377,007 |
| Net profit margin | −153.18% | −135.43% | −407.21% | −359.87% | −2,942.42% | −10,703.47% | −8,335.20% | −4,105.61% | −1,289.31% |
| Basic EPSper basic share | -$0.62 | -$0.44 | -$0.79 | -$0.45 | -$1.12 | -$0.63 | -$0.47 | -$0.50 | -$0.11 |
| Diluted EPSper diluted share | -$0.62 | -$0.44 | -$0.79 | -$0.45 | -$1.12 | -$0.63 | -$0.47 | -$0.50 | -$0.11 |
Owners
Reported shareholders